摘要
肺动脉高压(pulmonary hypertension,PH)是以肺小动脉的收缩、肺血管重塑、血栓形成为主要病理特征的渐进性疾病。血管舒缩因子、血管生长因子、炎性因子、低氧诱导因子等多种细胞因子共同参与PH的发病过程,现有药物治疗效果不理想。因此,寻找有效防治PH的药物迫在眉睫。我国中药资源丰富,运用中药治疗PH的历史悠久,因此,从天然产物中筛选和开发疗效确切、安全无毒的防治PH的药物具有得天独厚的优势。近年来,一些学者的研究表明中药防治PH有较好的疗效。该文将对部分中药单体、单味中药及中药复方制剂在PH治疗中的作用及其机制进行综述。
Pulmonary hypertension(PH)is a progressive disease characterized mainly by the contraction of pulmonary arterioles,pulmonary vascular remodeling and thrombosis.Vasoconstriction factor,vascular growth factor,inflammatory factors,hypoxia inducible factor and other cytokines participate in the pathogenesis of PH.Due to the unsatisfactory therapeutic effect of existing drug treatment,it is urgent to look for the effective prevention and treatment of PH.Our country is rich in traditional Chinese medicine and has a long history of using traditional Chinese medicine to treat PH.Therefore,it is of unique advantage to screen and develop the effective,safe and nontoxic PH drugs from natural products.Recent studies have shown that Chinese medicine has a better curative effect on pulmonary hypertension.In this paper,the effects of Chinese medicine monomers and other natural products in treatment of PH and its mechanisms have been reviewed.
作者
赵方允
王琰
张春芳
王紫微
张悦
邢西迁
杨姣
ZHAO Fang-yun;WANG Yan;ZHANG Chun-fang;WANG Zi-wei;ZHANG Yue;XING Xi-qian;YANG Jiao(College of Pharmacy,Yan’an Hospital Affiliated to Kunming Medical University,Kunming 650051,China;the First Dept of Respiratory Medicine,Yan’an Hospital Affiliated to Kunming Medical University,Kunming 650051,China;the First Dept of Respiratory Medicine,the First Affiliated Hospital of Kunming Medical University,Kunming 650032,China)
出处
《中国药理学通报》
CAS
CSCD
北大核心
2018年第11期1496-1500,共5页
Chinese Pharmacological Bulletin
基金
国家自然科学基金资助项目(No 81560694
81760015
81360049)
云南省中青年学术和技术带头人后备人选培养计划(No 2017HB053)
昆明市卫生科技人才暨"十百千"工程(No 2016SWRC086)
关键词
肺动脉高压
治疗
中药
抗血栓形成
抗血管炎症反应
扩张肺血管
抑制肺动脉平滑肌细胞增殖
pulmonary hypertension
treatment
traditional Chinese medicine
antithrombotic formation
inhibition of vascular inflammation
dilatation of pulmonary vessels
inhibition of proliferation of pulmonary artery smooth muscle cells
作者简介
赵方允(1983-),男,硕士,主管药师,研究方向:肺动脉高压的基础,E-mail:zhaofangyun@126.com;邢西迁(1980-),男,硕士,副教授,硕士生导师,研究方向:肺动脉高压的基础与临床,通讯作者,E-mail:xingxiqianmd@yahoo.com;杨姣(1980-),女,硕士,讲师,研究方向:肺动脉高压的基础与临床,通讯作者,E-mail:yangjiaokmu@yahoo.com。
